정상체온 기계 관류 시장 보고서(2025년)
Normothermic Machine Perfusion Global Market Report 2025
상품코드 : 1760655
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전 세계 정상체온 기계 관류 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년에는 16.2%의 연평균 성장률로 27억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 한계 기증 장기 활용에 대한 수요 증가, NMP를 통한 이식 성공률 향상, 임상시험 및 규제 승인 증가, 장기 보존 기술에 대한 투자 증가, 신흥국에서의 광범위한 채택으로 인해 발생할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 AI를 활용한 모니터링 활용, 기기 소형화, 원격의료 플랫폼과의 통합, 한계 기증 장기 및 DCD(순환사 후 기증) 장기 적용, 다장기 관류 시스템 개발, 생체적합성 재료의 발전 등이 있습니다.

장기 이식에 대한 수요 증가는 정상체온 기계 관류 시장의 성장을 견인할 것으로 예상됩니다. 장기 이식은 기능부전이나 질병에 걸린 장기를 기증자의 건강한 장기로 대체하는 것을 포함합니다. 장기 이식에 대한 수요 증가는 만성질환으로 인한 말기 장기 부전의 유병률 증가와 수술 기술 및 면역 억제 요법의 발전으로 인해 증가하고 있습니다. 정상체온 기계 관류는 기증자의 장기가 이식될 때까지 산소가 함유된 혈액과 관류액으로 체온을 유지함으로써 장기 보존과 소생에 중요한 역할을 합니다. 예를 들어, 2024년 1월 미국 보건복지부는 2023년 4,6,632건의 장기 이식이 이루어졌으며, 2022년 대비 8.7% 증가했다고 보고했습니다. 이러한 장기 이식에 대한 수요 증가가 정상체온 기계 관류 시장 성장을 견인하고 있습니다.

정상체온 기계 관류 시장의 주요 기업들은 기술 혁신을 촉진하고 장기 보존 기술을 강화하며 이식 결과를 개선하기 위해 첨단 연구 시설을 설립하는 데 주력하고 있습니다. 이러한 시설의 확충은 장기 보존, 연구 및 임상 응용 능력을 향상시켜 이식 성공률과 가용성을 모두 향상시킬 수 있습니다. 예를 들어, 2024년 5월 영국의 의료기기 회사 OrganOx Ltd.는 옥스퍼드에 18,000평방피트 규모의 연구 개발 시설을 신설했습니다. 이번 확장은 전 세계적으로 간 이식 치료 성적을 향상시킨 메트라(Metra) 장비의 성공을 바탕으로 기술 혁신을 추진하고 파트너십을 촉진하는 것을 목표로 하고 있습니다. 회사는 기술을 통해 과학적 및 임상적 혁신을 촉진하고 장기부전 대응을 더욱 강화할 수 있다고 낙관적으로 보고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장의 고성장 가능성 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Normothermic machine perfusion is a preservation method where organs are kept at normal body temperature (around 37°C) and provided with oxygenated blood or perfusate to replicate physiological conditions. This technique supports improved organ viability, functional assessment, and extended preservation time before transplantation.

The primary products in normothermic machine perfusion include portable and stationary normothermic machines. Portable devices are compact, mobile systems designed to preserve donor organs at a body temperature of around 37°C during transportation. These machines function using various advanced technologies, such as mechanical circulation, oxygenation systems, and monitoring systems. Major applications include organ preservation, transplantation, and research and development, with use spanning hospitals, ambulatory surgery centers (ASCs), specialty clinics, and other healthcare settings.

The normothermic machine perfusion market research report is one of a series of new reports from The Business Research Company that provides normothermic machine perfusion market statistics, including the normothermic machine perfusion industry global market size, regional shares, competitors with the normothermic machine perfusion market share, detailed normothermic machine perfusion market segments, market trends, and opportunities, and any further data you may need to thrive in the normothermic machine perfusion industry. This normothermic machine perfusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The normothermic machine perfusion market size has grown rapidly in recent years. It will grow from $1.28 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. Growth during the historic period was driven by rising organ demand, better preservation outcomes, an increase in donor age and use of marginal organs, regulatory support, growing investments in medical technologies, and the need to minimize cold ischemia time.

The normothermic machine perfusion market size is expected to see rapid growth in the next few years. It will grow to $2.73 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. Growth in the forecast period is expected to result from higher demand for marginal donor organ utilization, improved transplant success rates with NMP, an increase in clinical trials and regulatory approvals, rising investments in organ preservation technologies, and broader adoption in emerging economies. Key trends projected for the forecast period include the use of AI-powered monitoring, device miniaturization, integration with telemedicine platforms, application to marginal and DCD (donation after circulatory death) organs, development of multi-organ perfusion systems, and advancements in biocompatible materials.

The growing demand for organ transplantation is expected to drive the expansion of the normothermic machine perfusion market. Organ transplantation involves replacing a malfunctioning or diseased organ with a healthy one from a donor. The increasing need for transplants is fueled by the rising prevalence of end-stage organ failure, often due to chronic diseases, as well as advancements in surgical techniques and immunosuppressive therapies. Normothermic machine perfusion plays a critical role in preserving and reviving donor organs by maintaining them at body temperature with oxygenated blood or a perfusate until they are transplanted. For example, in January 2024, the U.S. Department of Health & Human Services reported that 46,632 organ transplants were performed in 2023, marking an 8.7% increase over 2022. This growing demand for organ transplants is driving market growth for normothermic machine perfusion.

Key players in the normothermic machine perfusion market are concentrating on establishing advanced research facilities to foster innovation, enhance organ preservation technologies, and improve transplant outcomes. Expanding these facilities boosts the capacity for organ preservation, research, and clinical application, which in turn enhances both transplant success rates and availability. For example, in May 2024, OrganOx Ltd., a UK-based medical equipment company, opened a new 18,000 sq. ft. research and development facility in Oxford. This expansion is aimed at advancing innovation and fostering partnerships, building on the success of its Metra device, which has improved liver transplant outcomes worldwide. The company remains optimistic about advancing both scientific and clinical innovations through technology to better address organ failure.

In March 2025, OrganOx Ltd. partnered with ProCure On Demand Ltd. to enhance donor liver recovery and evaluation for transplantation. By combining OrganOx's normothermic machine perfusion system with ProCure's skilled surgical team and extensive service network, the collaboration aims to provide flexible, comprehensive solutions tailored to the specific needs of transplant centers, ultimately improving transplant efficiency and patient outcomes. ProCure On Demand is a U.S.-based healthcare company specializing in human organ transplantation.

Major players in the normothermic machine perfusion market are CVS Health Corporation, Medtronic plc, Tandem Diabetes Care Inc., Fluent Medical Inc., TransMedics Inc., XENIOS AG, RVL Pharmaceuticals plc, Xvivo Perfusion AB, LifePort Inc., Lifeline Scientific Inc., Organ Recovery Systems Inc., Bridge to Life Ltd., OrganOx Limited, Paragonix Technologies Inc., SurgiCor LLC, Waters Medical Systems LLC, InnovaHealth Partners LP, Prescient Surgical Inc., Vascular Insights LLC, and Lung Bioengineering Inc.

North America was the largest region in the normothermic machine perfusion market in 2024. The regions covered in normothermic machine perfusion report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the normothermic machine perfusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The normothermic machine perfusion market includes revenues earned by entities by providing services such as organ viability assessment, logistics and transport solutions, and organ repair and reconditioning. The market value includes the value of related goods sold by the service provider or included within the service offering. The normothermic machine perfusion market also includes sales of perfusion systems, kits, bioreactors, sensors, and monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Normothermic Machine Perfusion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on normothermic machine perfusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for normothermic machine perfusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The normothermic machine perfusion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Normothermic Machine Perfusion Market Characteristics

3. Normothermic Machine Perfusion Market Trends And Strategies

4. Normothermic Machine Perfusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Normothermic Machine Perfusion Growth Analysis And Strategic Analysis Framework

6. Normothermic Machine Perfusion Market Segmentation

7. Normothermic Machine Perfusion Market Regional And Country Analysis

8. Asia-Pacific Normothermic Machine Perfusion Market

9. China Normothermic Machine Perfusion Market

10. India Normothermic Machine Perfusion Market

11. Japan Normothermic Machine Perfusion Market

12. Australia Normothermic Machine Perfusion Market

13. Indonesia Normothermic Machine Perfusion Market

14. South Korea Normothermic Machine Perfusion Market

15. Western Europe Normothermic Machine Perfusion Market

16. UK Normothermic Machine Perfusion Market

17. Germany Normothermic Machine Perfusion Market

18. France Normothermic Machine Perfusion Market

19. Italy Normothermic Machine Perfusion Market

20. Spain Normothermic Machine Perfusion Market

21. Eastern Europe Normothermic Machine Perfusion Market

22. Russia Normothermic Machine Perfusion Market

23. North America Normothermic Machine Perfusion Market

24. USA Normothermic Machine Perfusion Market

25. Canada Normothermic Machine Perfusion Market

26. South America Normothermic Machine Perfusion Market

27. Brazil Normothermic Machine Perfusion Market

28. Middle East Normothermic Machine Perfusion Market

29. Africa Normothermic Machine Perfusion Market

30. Normothermic Machine Perfusion Market Competitive Landscape And Company Profiles

31. Normothermic Machine Perfusion Market Other Major And Innovative Companies

32. Global Normothermic Machine Perfusion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Normothermic Machine Perfusion Market

34. Recent Developments In The Normothermic Machine Perfusion Market

35. Normothermic Machine Perfusion Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기